Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Labcorp (LH)

Labcorp amends receivables facility, extends term to January 2029 and adds $125 million accordion

Neutral Impact 3 of 5 financing Written later

Labcorp amended its receivables purchase agreement on January 28, 2026, extending the scheduled termination date to January 26, 2029. The amendment adds a committed $125 million accordion that lets the subsidiary raise the facility limit from $700 million to up to $825 million on or before May 29, 2026. The filing describes this as a financing update rather than a change in operating results.

Key points

  • Scheduled termination date extended to January 26, 2029
  • Committed $125 million accordion lets facility limit rise from $700 million to up to $825 million by May 29, 2026
  • Removed the 0.10% SOFR adjustment previously added to capital accruing yield
  • Labcorp Receivables assets are not available to pay Labcorp's other creditors

The filing

CompanyLabcorp (LH)
Form8-K, current report
Filed with the SECJan 29, 2026, 4:15 PM ET
Accession number0000920148-26-000017

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.